Oramed trial of diabetes drug delivery tech enrolling patients; Feds give NYU grant to study siRNA;

> Israel's Oramed ($ORMD) said enrollment in the Phase IIb study of its drug delivering capsule for Type 2 diabetes is more than halfway complete. More

> The National Science Foundation awarded New York University's Polytechnic School of Engineering a three-year $300,000 grant to study drug delivery related to siRNA. More